A study for a 50 year old woman who takes Entresto - from FDA reports


183 females aged 50 (±5) who take the same drug are studied. This is a personalized study for a 50 year old female patient who has Hypertension. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Sep, 12, 2018

183 females aged 50 (±5) who take Entresto are studied.


Number of reports submitted per year:

Entresto for a 50-year old woman.

Information of the patient in this study:

  • Age: 50
  • Gender: female
  • Conditions: Hypertension
  • Drugs taken:
    • Entresto (sacubitril; valsartan)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Hairloss: 4 (2.19% of females aged 50 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  1. Breathing difficulty
  2. Fatigue (feeling of tiredness)
  3. Itching
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Mediastinitis (inflammation of the tissues in the mid-chest)
  6. Abdominal pain upper
  7. Wound secretion
  8. Headache (pain in head)
  9. Dizziness
  10. Hypotension (abnormally low blood pressure)
1 - 6 months:
  1. Hypotension (abnormally low blood pressure)
  2. Dizziness
  3. Fatigue (feeling of tiredness)
  4. Blood creatinine increased
  5. Breathing difficulty
  6. Hepatic enzyme increased
  7. Nausea and vomiting
  8. Cardiogenic shock (inadequate circulation of blood)
  9. Ventricular fibrillation (abnormally irregular heart rhythm)
  10. Wound secretion
6 - 12 months:
  1. Metastases to liver (cancer spreads to liver)
  2. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  3. Breast cancer
  4. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  5. Metastases to spleen (cancer spreads to spleen)
  6. Arrhythmias (irregular heartbeat)
  7. Gastric cancer (stomach cancer)
  8. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
1 - 2 years:
  1. Oral mucosal blistering (mouth ulcer)
  2. Hypersensitivity
  3. Angioedema (rapid swelling of the dermis)
  4. Swollen tongue (swelling of tongue)
  5. Urticaria (rash of round, red welts on the skin that itch intensely)
  6. Swelling face
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  1. Hypotension (abnormally low blood pressure)
  2. Fatigue (feeling of tiredness)
  3. Breathing difficulty
  4. Cough
  5. Death
  6. Dizziness
  7. Cardiac failure
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Fluid retention (an abnormal accumulation of fluid in the blood)
  10. Blood creatinine increased

Top conditions involved for these people *:

  1. Cardiac Failure : 64 people, 34.97%
  2. Cardiac Failure Congestive : 19 people, 10.38%
  3. Cardiac Failure Chronic : 16 people, 8.74%
  4. Preventive Health Care : 6 people, 3.28%
  5. Left Ventricular Failure (left ventricle fails to contract forcefully): 5 people, 2.73%
  6. Diabetes : 4 people, 2.19%
  7. Anaemia (lack of blood): 4 people, 2.19%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 1.64%
  9. Pain : 3 people, 1.64%
  10. Iron Deficiency : 3 people, 1.64%

Top co-used drugs for these people *:

  1. Lasix (15 people, 8.20%)
  2. Coreg (12 people, 6.56%)
  3. Metformin (9 people, 4.92%)
  4. Aldactone (8 people, 4.37%)
  5. Vitamin D3 (8 people, 4.37%)
  6. Lipitor (5 people, 2.73%)
  7. Sertraline (5 people, 2.73%)
  8. Vitamin B12 (5 people, 2.73%)
  9. Clopidogrel (4 people, 2.19%)
  10. Crestor (4 people, 2.19%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:



Related studies:

Related publications that referenced our studies

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!